NEFL and Parkinson disease: In the KCL cohort, the concentrations of plasma NfL were significantly increased in all cognitively impaired, parkinsonian, DSAD, and ALS compared to the CU Aβ− group (P < 0.0001, Fig. 1A), with the exception of PD, DS, depression, and EOAD groups.